PHARMACEUTICALS CONTAINING PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS

To provide pharmaceuticals containing pyrazolo[1,5-a]pyrimidine compounds or pharmaceutically acceptable salts thereof and having PAR2 inhibitory activity.SOLUTION: A pharmaceutical product contains a compound of general formula [I] or a pharmaceutically acceptable salt thereof, where each symbol in...

Full description

Saved in:
Bibliographic Details
Main Authors SAITO AKIHIRO, TAKAHASHI AKIRA, MATSUDA SATOSHI, MENJO YASUHIRO, HANARI YASUTAKA, NAKAMURA YUICHI, YAMAGUCHI ATSUSHI, OKADA MINORU, WATANABE KENJI, UEMATSU YUKITAKA, YAMAUCHI TAKAHITO, YUKI YOHEI
Format Patent
LanguageEnglish
Japanese
Published 19.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To provide pharmaceuticals containing pyrazolo[1,5-a]pyrimidine compounds or pharmaceutically acceptable salts thereof and having PAR2 inhibitory activity.SOLUTION: A pharmaceutical product contains a compound of general formula [I] or a pharmaceutically acceptable salt thereof, where each symbol in the formula is as described in the specification.SELECTED DRAWING: None 【課題】PAR2阻害作用を有する、ピラゾロ[1,5-a]ピリミジン化合物またはその薬学的に許容される塩を含む医薬を提供すること。【解決手段】 一般式[I]:JPEG2024082263000091.jpg3969[式中、各記号は、明細書に記載のとおりである。]の化合物またはその薬学的に許容される塩を含む医薬。【選択図】なし
Bibliography:Application Number: JP20230205786